In the News
More sites seek ‘partner of choice’ label
Rhonda Henry says sponsors and CROs are looking for shared commitment, consistency and predictability when selecting a partner of choice.
A valued perspective
This article by David Blackman outlines how advancements in mHealth technologies within clinical trials hope to improve practices and explore new markets.
Rare Disease Recruitment Models Evolving
Karen Kaucic, M.D., discusses how the move toward precision medicine is going to require a paradigm shift within the pharmaceutical ecosystem.
PPD and Acurian launch patient concierge for clinical trials
Nik Morton and Roger Smith explain that the goal of the new service is to increase patient engagement and retention.
Changing the face of the clinical trials industry
Chris Clendening and Brent Reed discuss the PPD® Laboratories Preclarus® investigator site portal and companion mobile application, which were acknowledged for industry leadership in the CenterWatch Monthly 25th anniversary special edition, which spotlights top innovators in clinical research.
PPD, Quotient Sciences pen pact to speed up therapies aimed at kids
Collaboration will enable the companies to jointly provide a one-of-a-kind offering that meets the needs of patients and regulators in the development of pediatric drug products.
PPD Partners With UK Firm To Speed Pediatric Drug Development
Karen Kaucic explains that the new program was established in response to increasing customer demand, as well the drive by regulatory agencies to promote the development of new medicines for children.
PPD, Quotient to support entire pediatric program through single contract
Karen Kaucic announces a new collaboration to accelerate pediatric drug development.
Single-Use Bioreactors Pose E&L Challenges
Derek Wood comments on the challenges posed by single-use bioreactor bags in contributing to extractables and leachables in the biomanufacturing process.
